Fire Capital Management LLC Has $777,000 Position in Danaher Corporation $DHR

Fire Capital Management LLC boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 4.6% during the second quarter, Holdings Channel reports. The institutional investor owned 3,935 shares of the conglomerate’s stock after acquiring an additional 174 shares during the quarter. Fire Capital Management LLC’s holdings in Danaher were worth $777,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the business. Mendel Money Management raised its position in Danaher by 1.7% in the second quarter. Mendel Money Management now owns 23,156 shares of the conglomerate’s stock worth $4,574,000 after purchasing an additional 378 shares in the last quarter. Austin Private Wealth LLC grew its stake in shares of Danaher by 4.1% in the 2nd quarter. Austin Private Wealth LLC now owns 1,930 shares of the conglomerate’s stock valued at $381,000 after purchasing an additional 76 shares during the period. New York Life Investment Management LLC lifted its position in shares of Danaher by 1.2% during the 2nd quarter. New York Life Investment Management LLC now owns 86,821 shares of the conglomerate’s stock worth $17,151,000 after buying an additional 1,061 shares during the period. Boyd Watterson Asset Management LLC OH lifted its position in shares of Danaher by 2.1% during the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after buying an additional 51 shares during the period. Finally, Howard Capital Management Inc. boosted its stake in Danaher by 26.1% in the 2nd quarter. Howard Capital Management Inc. now owns 4,932 shares of the conglomerate’s stock valued at $974,000 after buying an additional 1,020 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $216.89 on Wednesday. The firm has a market cap of $153.20 billion, a price-to-earnings ratio of 44.72, a PEG ratio of 3.39 and a beta of 0.77. The company has a 50 day moving average of $203.06 and a 200-day moving average of $199.03. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the business posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on DHR shares. Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday. Wells Fargo & Company reiterated a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. JPMorgan Chase & Co. upped their price target on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Finally, Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $243.39.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 11.20% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.